Isomorphic Labs (Series A)
Funding Details
Awarder
Inbox
Date Award
August 14, 2025
Vertical
AI Techbio
Funding URL
View Funding Page
Funding Amount
$600,000,000
Company Info
Founding Year
2021
Traction
Isomorphic Labs has secured $82.5m upfront from deals with Novartis and Eli Lilly, with potential future value nearing $3bn.
Organizations Involved
Novartis, Eli Lilly
Founders
Colin Murdoch, Demis Hassabis
Market
Pharmaceuticals
Location
London, United Kingdom
Coinvestors
Thrive Capital, GV
Company Description

Isomorphic Labs is a London-based AI techbio that spun out of Google DeepMind in 2021 to commercialise a drug discovery platform, leveraging DeepMind's AlphaFold technology to transform the drug discovery process.

Links
Back to HomeBack to AI Techbio DealsView Funding Announcement